Infliximab does not increase colonic cancer risk associated to murine chronic colitis

AIM: To explore the influence of Infliximab (IFX) on cancer progression in a murine model of colonic cancer associated to chronic colitis. METHODS: AOM/DSS model was induced in C57BL/6 mice. Mice were injected with IFX (5 mg/kg) during each DSS cycle while control mice received saline. Body weight,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: Lopetuso, Loris R, Petito, Valentina, Zinicola, Tiziano, Graziani, Cristina, Gerardi, Viviana, Arena, Vincenzo, Caristo, Maria Emiliana, Poscia, Andrea, Cammarota, Giovanni, Papa, Alfredo, Cufino, Valerio, Sgambato, Alessandro, Gasbarrini, Antonio, Scaldaferri, Franco
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2016
Konular:
Basic Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124977/
https://ncbi.nlm.nih.gov/pubmed/27956796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i44.9727
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller